ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ILMN Illumina Inc

105.495
-1.90 (-1.76%)
Last Updated: 13:20:06
Delayed by 15 minutes

Period:

Draw Mode:

Volume 859,270
Bid Price 105.49
Ask Price 105.56
News -
Day High 107.365

Low
89.00

52 Week Range

High
213.91

Day Low 104.66
Share Name Share Symbol Market Stock Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-1.90 -1.76% 105.495 13:20:06
Open Price Low Price High Price Close Price Previous Close
106.69 104.66 107.365 107.39
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
20,828 859,270 US$ 106.05 US$ 91,128,101 - 89.00 - 213.91
Last Trade Type Quantity Price Currency
13:20:06 average 100 US$ 105.5337 USD

Illumina (ILMN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-143k

Calls / Puts

70.00%

Buys / Sells

166.67%

OTM / ITM

325.00%

Sweeps Ratio

0.00%

Illumina Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
16.85B 158.90M - 4.5B -1.16B -7.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Illumina News

Date Time Source News Article
5/22/202416:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/22/202416:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/20/202415:27Edgar (US Regulatory)Form SD - Specialized disclosure report
5/20/202415:09Edgar (US Regulatory)Form 8-K - Current report
5/20/202415:05PR Newswire (US)Anna Richo joins Illumina's Board of Directors
5/17/202417:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/17/202417:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ILMN Message Board. Create One! See More Posts on ILMN Message Board See More Message Board Posts

Historical ILMN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week114.40115.1799104.66109.211,490,667-8.91-7.78%
1 Month121.97127.745104.66114.931,633,715-16.48-13.51%
3 Months143.97146.08104.66124.911,604,494-38.48-26.72%
6 Months97.00148.1993.51127.941,910,9988.508.76%
1 Year208.13213.9189.00139.431,900,213-102.64-49.31%
3 Years403.04526.0089.00213.341,396,789-297.55-73.83%
5 Years310.00555.7789.00254.941,289,089-204.51-65.97%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Your Recent History

Delayed Upgrade Clock